1. P666: ACALABRUTINIB ± OBINUTUZUMAB VS OBINUTUZUMAB + CHLORAMBUCIL IN TREATMENT-NAIVE CHRONIC LYMPHOCYTIC LEUKEMIA: 5-YEAR FOLLOW-UP OF ELEVATE-TN. (23rd June 2022) Authors: Sharman, J. P.; Egyed, M.; Jurczak, W.; Skarbnik, A.; Patel, K.; Flinn, I. W.; Kamdar, M.; Munir, T.; Walewska, R.; Fogliatto, L. M.; Herishanu, Y.; Banerji, V.; Follows, G.; Walker, P.; Karlsson, K.; Ghia, P.; Janssens, A.; Cymbalista, F.; Ferrant, E.; Wierda, W. G. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 564 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Rapid improvement in symptoms and physical function following ibrutinib initiation in chronic lymphocytic leukemia and the associated changes in plasma cytokines. (October 2021) Authors: Ishdorj, G.; Nugent, Z.; Squires, M.; Kost, S.; Banerji, V.; Davidson, L.; Katyal, C.S.; Marshall, A.; Gibson, S.B.; Johnston, J.B. Journal: Leukemia research Issue: Volume 109(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Topic: AS02-Epidemiology: THE IMPACT OF GAINING OR LOSING TRANSFUSION INDEPENDENCE ON QUALITY OF LIFE IN MYELODYSPLASTIC SYNDROMES. (September 2021) Authors: Brailovski, E.; Mozessohn, L.; Abel, G.; Geddes, M.; Zhu, N.; Keating, M.-M.; Sabloff, M.; Christou, G.; Leber, B.; Khalaf, D.; Leitch, H.; Hilaire, E. St.; Finn, N.; Shamy, A.; Yee, K.; Storring, J.; Nevill, T.; Delage, R.; Elemary, M.; Banerji, V. Journal: Leukemia research Issue: Volume 108(2021)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗